This growing interest is reflected in a consistent rise in requests for ADAMTS-13 tests referred from hematologists linked to advancements in diagnosing and managing acute TTP patients during follow-up. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.